Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Jinbo
company
About
Jinbo is a functional biological protein product developer and research company.
- 251 - 500
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- ¥70.07M
- Industries
- Biotechnology,Medical,Pharmaceutical
- Founded date
- Mar 28, 2008
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
¥105.60M
Jinbo has raised a total of
¥105.60M
in funding over 2 rounds. Their latest funding was raised on
Feb 22, 2017 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 22, 2017 | Post-IPO Equity | ¥70.07M | 1 | — | — | Detail |
| Oct 19, 2015 | Post-IPO Equity | ¥25.53M | 1 | — | — | Detail |
| Dec 31, 2014 | Angel | ¥10M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Jinbo is funded by 2 investors.
Hongrun Shengwu
and Qianzhou Qingyuan Investment
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Post-IPO Equity |
|
|
— | Post-IPO Equity |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
